Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 485.65
   
  • Change Today:
    $-0.38
  • 52 Week High: $522.18
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 1,568,035
  • Market Cap: $114,609m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 485.65
Change Today $ -0.38
% Change -0.08 %
52 Week High $522.18
52 Week Low $374.46
Volume 1,568,035
Shares Issued 235.99m
Market Cap $114,609m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 5
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Jul-2026

Time Volume / Share Price
15:59 300 @ $485.64
15:59 40 @ $485.64
15:59 40 @ $485.56
15:59 40 @ $485.56
15:59 160 @ $485.64

Top of Page